A Food and Drug Administration (FDA) advisory committee has voted 11 to 2 against a recommendation that the agency approve a long-studied antiarrhythmic agent for cardioversion of recent-onset atrial ...

La cardioversion est proche de la défibrillation mais l'équipe médicale utilise un courant moins fort. Cela se fait grâce à deux palettes métalliques posées sur le thorax et reliées à un ...

Cardioversion is a medical procedure to correct a heartbeat that is irregular or too fast. It can involve risks and side effects but is generally safe and effective. Doctors primarily use ...

But the current study, from Dr Gaetano M De Ferrari (University of Pavia, Italy) and colleagues, suggests that there can be a role for cardioversion in some populations, in this case patients with ...

Patients with recent-onset atrial fibrillation commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether immediate restoration of sinus ...

ATRIAL fibrillation is one of the most prevalent of the chronic rhythm disorders of the heart. It is a derangement with serious implications. Even when the patient is asymptomatic the arrhythmia is by ...

VANCOUVER, June 12, 2015 /CNW/ - Cardiome Pharma Corp. (NASDAQ: CRME /TSX: COM) today announced that an independent study conducted by investigators at the University of Leipzig Heart Center, Germany, ...

Warfarin, dabigatran and rivaroxaban are safe periprocedural anticoagulation options for patients undergoing cardioversion or ablation for atrial fibrillation, according to researchers in Canada. “We ...

Electrical cardioversion without routine extra anticoagulation around the procedure may be feasible for people who've already received left atrial appendage (LAA) occlusion, according to a small ...